Voronoi, Inc. Logo

Voronoi, Inc.

Biotech firm developing therapeutics using an AI drug discovery platform.

310210 | KO

Overview

Corporate Details

ISIN(s):
KR7310210000
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 에스동 18층, 연수구

Description

Voronoi, Inc. is a biotechnology company that specializes in the research and development of novel therapeutics for challenging diseases. The company's core expertise lies in creating innovative small molecule kinase inhibitors and target protein degrader drugs. Utilizing its proprietary AI-powered drug discovery platform, VORONOMICS, Voronoi accelerates the identification and optimization of promising drug candidates. This platform enables the rapid design of therapies with high selectivity and brain penetration, primarily targeting various forms of cancer and other difficult-to-treat conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2024-03-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.4 KB
2024-03-12 00:00
주식등의대량보유상황보고서(일반)
Korean 109.2 KB
2024-02-20 00:00
주식등의대량보유상황보고서(일반)
Korean 93.5 KB
2024-02-15 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.0 KB
2024-01-30 00:00
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정)(VRN110755의 제1상 임상시험계획 승인)
Korean 15.5 KB
2023-12-28 00:00
주식등의대량보유상황보고서(일반)
Korean 91.1 KB
2023-12-14 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2023-12-06 00:00
주식매수선택권행사
Korean 22.2 KB
2023-12-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2023-12-06 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.3 KB
2023-12-06 00:00
주식등의대량보유상황보고서(일반)
Korean 96.4 KB
2023-12-06 00:00
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청)(표피성장인자 수용체(EGFR) 돌연변이 비소세포폐암(NSCLC) 환자에서 VRN1107…
Korean 12.8 KB
2023-12-01 00:00
주식등의대량보유상황보고서(일반)
Korean 89.5 KB
2023-11-23 00:00
주식등의대량보유상황보고서(일반)
Korean 88.5 KB

Automate Your Workflow. Get a real-time feed of all Voronoi, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Voronoi, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Voronoi, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.